At a glance
ClinicalIndex Comparison RecordN/ACompleted· 97 enrolled
Drug / intervention
B-Laser™ Atherectomy Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Effectiveness Evaluation of Eximo Medical's B-Laser™ Atherectomy Device, in Subjects Affected With Infrainguinal PAD
In Brief
A clinical study evaluating B-Laser™ Atherectomy System for PAD. Completed, enrolled 97 participants across 11 sites in 3 countries.
Detailed Summary
This is a prospective, single-arm, multi-center, international, open-label, clinical study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPAD
CountriesAustria, Italy, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartSep 2017
Primary CompletionApr 2018
Study CompletionOct 2018
TodayJul 2026
First PostedMay 17, 2017
Enrollment StartSep 6, 2017
Primary CompletionApr 27, 2018
Study CompletionOct 11, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.1 years ago
Interventions
B-Laser™ Atherectomy Systemdevice
The B-Laser™ is indicated for use for atherectomy of infrainguinal stenoses